JMP Securities Reaffirms “Market Outperform” Rating for Privia Health Group (NASDAQ:PRVA)

Privia Health Group (NASDAQ:PRVA)‘s stock had its “market outperform” rating reaffirmed by stock analysts at JMP Securities in a research note issued on Friday,Benzinga reports. They presently have a $26.00 price objective on the stock. JMP Securities’ price objective indicates a potential upside of 3.01% from the stock’s previous close.

A number of other research firms also recently commented on PRVA. Truist Financial increased their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, November 8th. JPMorgan Chase & Co. raised their price objective on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Friday, November 29th. Barclays lifted their target price on Privia Health Group from $19.00 to $21.00 and gave the stock an “equal weight” rating in a research report on Friday, November 8th. Needham & Company LLC began coverage on shares of Privia Health Group in a research note on Friday, January 10th. They set a “buy” rating and a $25.00 price target for the company. Finally, Macquarie started coverage on shares of Privia Health Group in a research report on Monday, December 16th. They set an “outperform” rating and a $25.00 price objective on the stock. Two investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and two have issued a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of “Buy” and an average price target of $24.94.

Privia Health Group Stock Up 1.5 %

Shares of PRVA opened at $25.24 on Friday. The company has a market capitalization of $3.03 billion, a price-to-earnings ratio of 252.43, a price-to-earnings-growth ratio of 3.07 and a beta of 0.87. Privia Health Group has a 52-week low of $15.92 and a 52-week high of $25.49. The stock has a 50 day moving average price of $21.62 and a 200 day moving average price of $20.23.

Hedge Funds Weigh In On Privia Health Group

Institutional investors and hedge funds have recently made changes to their positions in the stock. GAMMA Investing LLC increased its stake in Privia Health Group by 98.7% in the 3rd quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after purchasing an additional 845 shares in the last quarter. First Horizon Advisors Inc. increased its stake in Privia Health Group by 53.8% in the fourth quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company’s stock valued at $35,000 after purchasing an additional 632 shares during the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company’s stock valued at $47,000 after acquiring an additional 2,350 shares during the last quarter. Financial Management Professionals Inc. acquired a new position in Privia Health Group during the fourth quarter worth approximately $51,000. Finally, Quarry LP raised its position in shares of Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company’s stock worth $60,000 after buying an additional 2,533 shares during the period. 94.48% of the stock is owned by institutional investors and hedge funds.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.